Introduction
Orientia tsutsugamushi is an obligate intracellular bacterium that is the causative agent of scrub typhus, which is an acute febrile and fatal disease characterized by fever, rash, eschar, pneumonitis, and meningitis in humans [17, 35] . It has been reported that a virulent strain of O. tsutsugamushi can be accompanied by hemorrhage and intravascular coagulation, which, in untreated cases, can lead to severe multi-organ failure [14] .
Scrub typhus is a skin infection that is initiated when the host is bitten by an O. tsutsugamushi-infected trombiculid mite [15] . After infection, it is likely that dendritic cells (DCs) in the skin play an important sentinel role, because they are responsible for initial antigen-specific immune responses. Although several studies have investigated O. tsutsugamushi infections in macrophages and endothelial cells [20, 30] , little is known about the effect of O. tsutsugamushi in DCs, particularly in the human immune system.
DCs are the major antigen-presenting cells (APCs) and play an important role in bridging innate and adaptive immune responses by presenting specific antigenic molecules to T cells [7, 28] . DC maturation occurs through multiple steps, including antigen uptake, migratory activity, expression of co-stimulatory molecules, and cytokine and chemokine secretion; through this pathway, DCs eventually gain the ability to activate T cells [12, 23] .
It is possible that O. tsutsugamushi could evade the action of DCs during infection, as has been documented in other cell types [27] . Although a large number of pathogens can persist inside DCs, the mechanisms by which O. tsutsugamushi is internalized and survives in human DCs are not clearly understood. The induction of immune responses against O. tsutsugamushi in human DCs has not been thoroughly investigated. Thus, the main purpose of the present study was to examine the induction of innate immune responses in human DCs treated with O. tsutsugamushi and the ability of those DCs to activate CD4 + T cells.
Materials and Methods
Cell Culture L929 (a mouse fibroblast cell line) and ECV304 (an immortalized human umbilical vein endothelial cell line) were obtained from the American Type Culture Collection (Rockville, MD, USA) and cultured in DMEM and Medium 199 (Gibco BRL, USA), respectively. The media were supplemented with 10% fetal bovine serum (FBS; Gibco BRL), 5 mM L-glutamine, penicillin (100 U/ml), and streptomycin (100 µg/ml), and the cells were cultured in an incubator with a humidified atmosphere containing 5% CO 2 .
Propagation and Preparation of O. tsutsugamushi
O. tsutsugamushi (Boryong strain) was propagated in the monolayers of L929 cells as previously described [4] . Briefly, when more than 90% of the cells were infected (as measured by an indirect immunofluorescence antibody assay (IFA)), the cells were collected, homogenized using a glass Dounce homogenizer (Wheaton Inc., USA), and centrifuged at 500 ×g for 5 min. The supernatant was stored in liquid nitrogen until use. The infectivity titer of the inoculum was determined using an IFA. Briefly, the bacterial stock was serially diluted and inoculated onto a L929 cell layer on a 12 mm glass coverslip in a 24-well tissue culture plate. After the cells were infected with O. tsutsugamushi for 6 h at 34 Sera from patients with scrub typhus were used to detect O. tsutsugamushi infection. Fluorescein isothiocyanate (FITC)-conjugated goat anti-human IgG (Santa Cruz Biotechnology, USA) was used as the secondary antibody. IFAs were performed as described previously [21] . To examine the infectivity of O. tsutsugamushi, 100 cells were counted for each experimental treatment set. The results were expressed as the mean number of infected cell count units (ICU) per cells ± standard deviation.
Preparation and Culture of Human MODCs
All experiments using human blood were performed under the approval of the Institutional Review Board of Seoul National University, Korea (IRB No. 0612/001-004). Peripheral blood mononuclear cells (PBMCs) were isolated from the blood of healthy donors by density gradient centrifugation using FicollPaque Plus (Amersham Bioscience, UK). CD14
+ monocytes were isolated from the PBMCs using the IMag anti-human CD14 antibody kit (BD Biosciences, USA). To generate MODCs, CD14
+ monocytes were seeded in a 6-well plate at a density of 3 × 10 6 cells per well in RPMI-1640 (Invitrogen, USA) supplemented with 10% FBS, 100 U/ml penicillin, 100 µg/ml streptomycin, 25 mM HEPES, 2 mM L-glutamine, 1 mM sodium pyruvate (all from Invitrogen), and 0.05 mM 2-mecaptoethanol (Sigma-Aldrich, USA) in the presence of 50 ng/ml human recombinant granulocytemacrophage colony-stimulating factor and 1,000 U/ml of human recombinant interleukin (IL)-4 (R&D Systems, USA) for 5 days. The cells were maintained in an atmosphere of 5% CO 2 at 37 o C, and the media were changed every 3 days.
Maturation of Human MODCs Treated with O. tsutsugamushi
MODCs were treated with a high or low dose of O. tsutsugamushi for 24 h. The cells were then washed three times with PBS and stained with the following maturation markers: anti-human CD80-PE, anti-human CD83-FITC, anti-human CD86-APC, anti-human CD40-FITC, and anti-human HLA-A.B.C-PE monoclonal antibodies (BD Biosciences). After staining for 15 min on ice, the cells were washed, and the expression of maturation markers was measured using a FACSCalibur with CellQuest software (BD Biosciences). All cytometric data were analyzed with FlowJo software (Tree Star, USA).
Proinflammatory Cytokine Production by MODCs Treated with O. tsutsugamushi
Proinflammatory cytokine secretion in the supernatants of O. tsutsugamushi-treated MODCs was measured by the cytometric bead array assay (BD Biosciences), according to the manufacturer's guidelines. Briefly, beads with distinct fluorescence intensities that were coated with capture antibody proteins were mixed with PE-conjugated detection antibodies and recombinant standards or samples; the beads were then incubated to form sandwich complexes at room temperature. After acquiring data using FACSCalibur, the cytokine concentrations were calculated using the proprietary FCAP array analysis software (Softflow, USA).
IFN-γ Production in MODC-T Cell Co-Culture
To co-culture CD4 + T cells with MODCs, PBMCs were purified by density gradient centrifugation using Ficoll-Paque Plus. CD4 + T cells were sorted from PBMCs using a FACS Aria (BD Biosciences). PBMCs were stained with anti-human CD3-APC and anti-human CD4-FITC monoclonal antibodies. Then, CD3 + and CD4 + doublepositive T cells were gated and sorted. The cell purity after sorting was >98%. O. tsutsugamushi-infected MODCs were co-cultured with CD4 + T cells for 72 h, and the culture supernatant was collected. The concentration of human IFN-γ in the supernatant was measured using a DuoSet ELISA kit (R&D Systems), according to the manufacturer's instructions.
Results

O. tsutsugamushi Continuously Proliferated After Infecting MODCs
To evaluate the infectivity and propagation of O. tsutsugamushi in MODCs, we treated MODCs with live or heat-killed O. tsutsugamushi. ECV304 cells were used as a positive control [4] . We found that live O. tsutsugamushi was able to infect MODCs and continued to proliferate in a time-dependent manner (Fig. 1) . As expected, a few heatkilled O. tsutsugamushi cells were phagocytized and did not replicate in MODCs (data not shown). These results revealed that, similar to O. tsutsugamushi infection of ECV304 cells, O. tsutsugamushi replicates during the first 48 h after infection in human MODCs. These results revealed a novel feature of O. tsutsugamushi invasion and replication in MODCs.
Maturation of Human MODCs Treated with O. tsutsugamushi
As DC maturation occurs, the expression of surface markers, including MHC class I and co-stimulatory molecules, increases. To examine the effect of infection on DC maturation, MODCs were treated with four different doses (LL, LH, HL, and HH) of O. tsutsugamushi. The surface expressions of CD80, CD83, CD86, MHC class I, and CD40 were enhanced on MODCs from all four treatment groups compared with MODCs that were not exposed to O. tsutsugamushi (Fig. 2) . The expressions of CD80, CD83, and MHC class I molecules were higher in MODCs treated with a high dose of O. tsutsugamushi than in MODCs treated with a low dose. Notably, there were no clear differences in the expressions of these molecules between MODCs treated with live or heat-killed O. tsutsugamushi.
O. tsutsugamushi Induced Proinflammatory Cytokine Production in MODCs
The inflammatory cytokines that are produced during the maturation of dendritic cells are critical to initiate the innate and adaptive immune responses [1] . Therefore, we examined cytokine production in O. tsutsugamushi-infected MODCs. The results showed that proinflammatory cytokines, including IL-6, IL-8, IL-12p70, and tumor necrosis factor (TNF)-α, all increased in MODCs treated with live O. tsutsugamushi for 24 h (Fig. 3) . For all cytokines examined, higher cytokine production was found in MODCs treated with live O. tsutsugamushi than in MODCs treated with heat-killed O. tsutsugamushi. As expected, stimulating MODCs with E. coli lipopolysaccharide (LPS) significantly increased the production of IL-6 and IL-8. Notably, the levels of IL-12p70 and TNF-α increased only moderately 24 h after LPS stimulation, whereas the levels were significantly higher in MODCs treated with live O. tsutsugamushi.
MODCs Treated with O. tsutsugamushi Promoted IFN-γ Secretion in T Cells
DC maturation is considered to be one of the key events in T cell priming [33] . To evaluate the T-cell priming ability of MODCs in response to O. tsutsugamushi infection, MODCs were treated with O. tsutsugamushi and then cocultured with sorted CD4 + T cells. The results showed that (Fig. 4) . Interestingly, the T cells co-cultured with the MODCs that had been treated with a high dose of heat-killed O. tsutsugamushi also produced substantial levels of IFN-γ (Fig. 4) .
Discussion
The major findings of this study are as follows: (i) Infected O. tsutsugamushi can replicate in MODCs; (ii) O. tsutsugamushi induces the maturation of MODCs, shown by the enhanced expressions of cell-surface CD80, CD83, CD86, and MHC class I molecules; (iii) O. tsutsugamushi induces IL-12p70 and TNF-α production in MODCs; and (iv) MODCs treated with O. tsutsugamushi preferentially induce IFN-γ production in T cells.
As a part of the essential host defense mechanism, bacteria including Shigella flexneri [19] and Listeria monocytogenes [11] are thought to progress to a degradation pathway (phagolysis) after uptake by MODCs; as a result, an antigenic peptide from the bacteria is presented together with the MHC to activate T cells [39] . However, a recent study reported that some bacteria can resist phagolysis in phagocytic cells [2, 34] .
After the internalization of O. tsutsugamushi into the skin, the bacteria can spread to other areas of the skin, lungs, brain, and other remaining organs via the bloodstream. O. tsutsugamushi infections result in rash, pneumonitis, and encephalitis [32, 35] . Despite the danger of O. tsutsugamushi, only a few studies have reported that O. tsutsugamushi can modulate human immune responses [35, 40] . Therefore, we investigated the activity of MODCs treated with O. tsutsugamushi. First, we infected MODCs with live O. tsutsugamushi and found that the number of intracellular O. Immature human MODCs were treated with PBS, different doses of live and heat-killed O. tsutsugamushi, or 100 ng/ml of E. coli LPS. After 24 h of incubation, human MODCs were stained with an appropriate combination of CD11c-APC, CD40-FITC, CD80-PE, CD83-FITC, CD86-PE, and MHC class I-FITC and analyzed by flow cytometry. All cytometric data are expressed as the mean fluorescence intensity (MFI) and were analyzed using FlowJo software. NT, non-treated; LL, live low-dose; LH, live high-dose; HL, heat-killed low-dose; HH, heat-killed high-dose of O. tsutsugamushi.
Representative data from three independent experiments are shown tsutsugamushi increased in a time-dependent manner, indicating that O. tsutsugamushi cells have the ability to resist phagolysis. Indeed, we previously reported that Shigella can replicate after infecting MODCs, using a unique lysosome escape system [19] . Therefore, our data suggested that O. tsutsugamushi has likely evolved an evasion mechanism against phagolysis.
It has been suggested in other models using intracellular bacterial infection that Shigella flexneri induces apoptosis in human monocyte-derived macrophages through a caspase-1 and IpaB-independent mechanism [19, 37] . Although the induction of cell death in DCs infected with live O. tsutsugamushi is yet to be further defined, live O. tsutsugamushi infection caused apoptosis in endothelial cells after disassembly of focal adhesion [18] and in a J774 murine macrophagelike cell line [3] . Based on these results, it is clear that live O. tsutsugamushi, like other intracellular bacteria, induces apoptosis in DCs during the infection. However, further studies are required for verifying the exact mechanism and stage of cell death during the maturation and replication in DCs.
A number of pathogenic bacteria, such as Staphylococcus aureus [24] and E. coli [5] , are well known to be good inducers of MODC maturation. We have found that, similar to other pathogenic bacteria, O. tsutsugamushi causes increased expression of cell-surface CD80, CD83, CD86, and MHC class I molecules. Because mature MODCs produce high levels of proinflammatory cytokines, we then examined cytokine production in MODCs treated with O. tsutsugamushi [31] . The results showed that O. tsutsugamushi induced an increase in the levels of IL-12p70, TNF-α, IL-6, and IL-8 in MODCs; these increases suggest that live O. tsutsugamushi, similar to LPS, can produce TNF-α, which plays an important role in inducing fever and disease severity [13] . Notably, live O. tsutsugamushi-infected MODCs, similar to LPS-treated MODCs, also produced high levels of IL-6 and IL-8, compared with levels in MODCs treated with heatkilled O. tsutsugamushi. IL-6 and IL-8 are well known for their ability to activate lymphocytes and induce neutrophil migration [10, 16] . Therefore, it is likely that these cytokines that are induced by infected DCs play an important role in controlling the severity and antigen-specific immune responses against O. tsutsugamushi. IL-12 is known to induce the differentiation of Th1 cells [38] , and our results indicate that MODCs treated with O. tsutsugamushi could preferentially induce Th1 cell activation. We also observed that live O. tsutsugamushi-infected MODCs could induce T cell stimulation, as shown by IFN-γ secretion, which is well known to play a critical role in inducing protective immunity against intracellular bacterial infections [26] . IFN-γ is also an important factor in the activation of infected macrophages to produce reactive oxygen species [25] and to directly kill intracellular pathogens, including L. monocytogenes [11] , Mycobacterium tuberculosis [6] , and Leishmania major [36] . IFN-γ production by activated CD4 + T cells inhibits the growth of O. tsutsugamushi in fibroblasts and macrophages in vitro [8, 9, 29] . It has been demonstrated that adoptively transferred CD4 + T cells that can produce IFN-γ induced protective immunity against O. tsutsugamushi infections in vivo [22] . This IFN-γ production could help CD8 + T cells to become cytotoxic T lymphocytes, which play a critical role in eliminating cells with intracellular pathogens [11] . One interesting finding from this study was that IFN-γ was induced in CD4 + T cells that had been co-cultured with
MODCs that had been treated with a high dose of heatkilled O. tsutsugamushi. Furthermore, whereas MHC class I and co-stimulatory molecules were enhanced in MODCs infected with a high dose of heat-killed O. tsutsugamushi, proinflammatory cytokines were induced at lower levels in these cells than in MODCs treated with a high dose of live O. tsutsugamushi. However, it is important to note that MODCs treated with high doses of heat-killed O. tsutsugamushi were still capable of priming T cells. These results show that heat-killed O. tsutsugamushi is a promising candidate for a vaccine that could activate the T cell-mediated immune response.
In conclusion, our study reveals that live O. tsutsugamushi has a mechanism for escaping phagolysis and replicating in MODCs. Furthermore, MODCs that are matured by live or heat-killed O. tsutsugamushi acquire the ability to activate CD4 + T cells.
